TrialPloS one2020

Successful direct-acting antiviral therapy improves circulating mucosal-associated invariant T cells in patients with chronic HCV infection.

Apichaya Khlaiphuengsin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.